Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: UNIPROT:P30536 (PBS)
 9,886 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

The lethal effect of near ultraviolet (NUV) with low intensity on cultured RPE cells has been investigated. RPE cultures with various cell densities were exposed to NUV (peaking at 365 nm) with or without ambient oxygen in phenol-red-free Dulbecco's PBS containing Ca2+, Mg2+ and glucose (PBS+). The cell viability was determined by dye exclusion and was expressed as cell death ratio (CDR, dead cells/total cells). When RPE cells at 5 x 10(3) cells/cm2, a non-contact low density, were irradiated either at a fixed irradiance (900 microW/cm2) with different exposure times (4 to 8h) or vice versa (8 h with irradiance from 430 to 900 microW/cm2), the change of CDR represented a similar linear function. The replotted data from both the time- and the irradiance-dependent curves indicated that the killing of RPE cells is dependent on the total energy dose of NUV. When a single NUV energy (19.44 J/cm2) was used, CDR was RPE cell density dependent. At confluence, NUV at the highest dosage tested (26 J/cm2) did not show any lethality. An oxygen-free condition abolished the NUV lethality on RPE cells even though the RPE cells were at a non-contact state. The presence of an antioxidant enzyme, catalase, in oxygen-saturated PBS+ protected RPE cells against NUV killing, but superoxide dismutase did not protect the RPE cells against NUV killing. These findings demonstrate that NUV possesses a lethal effect on RPE cells in vitro. Two key factors determine the magnitude and nature of this lethal effect: first, total NUV energy dose determines the nature of NUV's lethal effect; second, RPE growth conditions suggest the importance of cell-cell interaction in protecting these cells from NUV injury. Because an oxygen-free condition abolishes NUV lethality, it suggests that the oxidative stress is directly related to NUV lethal action. The selective inhibition by catalase of NUV killing of RPE cells suggests that the killing is oxidative species specific. NUV radiation might be highly risky to RPE viability in vivo, especially when the integrity of the RPE layer has been lost.
 ...
PMID:Characterization of lethal action of near-ultraviolet on retinal pigment epithelial cells in vitro. 897 37

Previous data from our laboratory and others have demonstrated a critical role for the CD4+ T lymphocyte in in vivo immune responses to recombinant adenoviral vectors. In rodent models, this subset of T cells is required for T cell proliferation, subsequent cytotoxic T cell generation, and production of anti-adenoviral antibodies by B cells. Both depleting and nondepleting anti-CD4 antibodies can attenuate these immune responses to recombinant adenovirus. On the basis of these data, we hypothesized that a nondepleting CDR-engrafted anti-human CD4 antibody (OKT4A) with cross-reactivity to rhesus macaques would attenuate both T and B cell responses to intrapulmonary administration of recombinant adenovirus and permit prolonged reporter gene expression and permit secondary gene transfer. Juvenile rhesus macaques were treated with PBS or OKT4A antibody (10 mg/kg) daily beginning 1 day prior to and up to 11 days after gene transfer. OKT4A resulted in significant attenuation of lymphocyte recruitment into the lung, lymphocyte-proliferative responses to both adenovirus capsid proteins and transgene protein, and adenovirus-induced interferon-gamma elaboration in whole blood and hilar lymph nodes. However, OKT4A was ineffective in attenuating adenovirus-induced IL-4 production in whole blood or hilar lymph nodes, generating neutralizing anti-adenoviral antibodies, or permitting secondary gene transfer. As all the monkeys in this protocol had baseline-detectable anti-adenoviral antibodies by ELISA that were nonneutralizing, analogous to most patients with cystic fibrosis, we postulate that anti-CD4 did not block the proliferation of memory B cells. Moreover, these data suggest that for transient immunomodulation to be successful, strategies need to focus specifically on B cell activation independent of CD4+ T cell help.
 ...
PMID:Immunomodulation and adenoviral gene transfer to the lungs of nonhuman primates. 1081 Dec 33